These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 622176)

  • 1. Direct or proximate contact between cells and metabolic activation systems is required for mutagenesis.
    Kuroki T; Drevon C
    Nature; 1978 Jan; 271(5643):368-70. PubMed ID: 622176
    [No Abstract]   [Full Text] [Related]  

  • 2. Divergence of metabolic activation systems for short-term mutagenesis assays.
    Selkirk JK
    Nature; 1977 Dec; 270(5638):604-7. PubMed ID: 593384
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of substrates and inhibitors of monoamine oxidase on hepatic dimethylnitrosamine metabolism and mutagenicity.
    Lake BG; Rowland IR; Harris RA; Collins MA; Phillips JC; Cottrell RC; Gangolli SD
    Adv Exp Med Biol; 1981; 136 Pt B():1143-7. PubMed ID: 6283820
    [No Abstract]   [Full Text] [Related]  

  • 4. The utilization of in vitro mutagenesis techniques to explain strain, age and sex related differences in dimethylnitrosamine tumor susceptibilities in mice.
    Brusick D; Jagannath D; Weekes U
    Mutat Res; 1976 Nov; 41(1 spel. no):51-60. PubMed ID: 796707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proceedings: Comparative mutagenicity studies with S. typhimurium of dimethylnitrosamine (DMN) and diethylnitrosamine (DEN), after metabolic activation with liver and lung microsomes.
    Malaveille C; Camus M; Montesano R; Bartsch H
    Mutat Res; 1975 Aug; 29(2):237-8. PubMed ID: 1102966
    [No Abstract]   [Full Text] [Related]  

  • 6. Biochemical and biological properties of prospective N-nitrodialkylamine metabolites and their derivatives.
    Frei E; Pool BL; Plesch W; Wiessler M
    IARC Sci Publ; 1984; (57):491-7. PubMed ID: 6398301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme specificity in the metabolic activation of N-nitrosodimethylamine to a mutagen for Chinese hamster V79 cells.
    Yoo JS; Yang CS
    Cancer Res; 1985 Nov; 45(11 Pt 1):5569-74. PubMed ID: 4053031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rat hepatocyte primary cell culture-mediated mutagenesis of adult rat liver epithelial cells by procarcinogens.
    San RH; Williams GM
    Proc Soc Exp Biol Med; 1977 Dec; 156(3):534-8. PubMed ID: 413114
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of cysteine and a liver metabolic activation system on the activities of mutagenic pesticides.
    Moriya M; Kato K; Shirasu Y
    Mutat Res; 1978 May; 57(2):259-63. PubMed ID: 351392
    [No Abstract]   [Full Text] [Related]  

  • 10. Some aspects of teratogenesis and mutagenesis in mammalian embryos.
    Bass R; Bochert G; Merker HJ; Neubert D
    J Toxicol Environ Health; 1977 Jul; 2(6):1353-74. PubMed ID: 328922
    [No Abstract]   [Full Text] [Related]  

  • 11. [Gene mutation induction by benz(a)pyrene following metabolic activation].
    Pashin IuV; Bakhitova LM
    Biull Eksp Biol Med; 1981 Sep; 92(9):327-9. PubMed ID: 6271305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple metabolic pathways for the mutagenic activation of 3-nitrobenzo[a]pyrene.
    Chou MW; Heflich RH; Fu PP
    Carcinogenesis; 1985 Aug; 6(8):1235-8. PubMed ID: 3893788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro metabolic activation in genotoxicity assays with mammalian cell cultures.
    Belvedere G
    Boll Chim Farm; 1985 Feb; 124(2):57-68. PubMed ID: 4015867
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhancement of dimethylnitrosamine metabolism and activation to a mutagen following chronic ethanol consumption.
    Garro AJ; Seitz HK; Lieber CS
    Cancer Res; 1981 Jan; 41(1):120-4. PubMed ID: 7192597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of microsomal and cytosolic fractions from rat, mouse, and hamster liver on the mutagenicity of dimethylnitrosamine in the Salmonella plate incorporation assay.
    Prival MJ; Mitchell VD
    Cancer Res; 1981 Nov; 41(11 Pt 1):4361-7. PubMed ID: 7030474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of glutathione and uridine 5'-diphosphoglucuronic acid on benzo(a)pyrene mutagenesis in the Salmonella/microsome assay.
    Malaveille C; Brun G; Hautefeuille A; Bartsch H
    Dev Toxicol Environ Sci; 1980; 8():175-80. PubMed ID: 6273102
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanism of metabolic activation of the analgetic bucetin to bacterial mutagens by hamster liver microsomes.
    Nohmi T; Ishidate M; Hiratsuka A; Watabe T
    Chem Pharm Bull (Tokyo); 1985 Jul; 33(7):2877-85. PubMed ID: 4085048
    [No Abstract]   [Full Text] [Related]  

  • 18. Improvement of short-term tests for mutagenicity: on the optimal pH for the liver microsomal assay.
    Paolini M; Sapigni E; Hrelia P; Grilli S; Lattanzi G; Cantelli-Forti G
    Carcinogenesis; 1988 Dec; 9(12):2265-70. PubMed ID: 3191571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell specificity in metabolic activation of aflatoxin B1 and benzo(a)pyrene to mutagens for mammalian cells.
    Langenbach R; Freed HJ; Raveh D; Huberman E
    Nature; 1978 Nov; 276(5685):277-80. PubMed ID: 714158
    [No Abstract]   [Full Text] [Related]  

  • 20. Improvement of the correlation of bacterial mutagenicity with carcinogenicity of benzo(a)pyrene and four of its major metabolites by activation with intact liver cells instead of cell homogenate.
    Glatt HR; Billings R; Platt KL; Oesch F
    Cancer Res; 1981 Jan; 41(1):270-7. PubMed ID: 7448766
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.